GlassScriptPhysician profile
Jason Sindledecker
NPI 1023406394
$2,628.85
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $597 · 2022: $826 · 2023: $871 · 2024: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,205.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $785.41 | 2021-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $768.15 | 2021-2024 | Xtampza, Belbuca |
| Protega Pharmaceutials INC | $214.19 | 2022-2023 | Roxybond |
| Abbvie INC. | $183.86 | 2021-2024 | |
| Scilex Pharmaceuticals INC. | $170.26 | 2022-2023 | Ztlido |
| Pfizer INC. | $95.34 | 2021-2023 | |
| Medtronic, INC. | $93.12 | 2022-2023 | |
| Ibsa Pharma INC. | $75.79 | 2021-2023 | Tirosint, Licart |
| Redhill Biopharma INC. | $37.52 | 2021 | |
| Tersera Therapeutics LLC | $35.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $27.10 | 2021 | |
| Almatica Pharma LLC | $26.50 | 2021 | |
| Alkermes, INC. | $24.78 | 2023 | Vivitrol |
| Nevro Corp. | $20.63 | 2024 | Senza |
| Amgen INC. | $17.77 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.41 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.56 | 2023 | Seglentis |
| Virtus Pharmaceuticals LLC | $12.84 | 2021 | |
| Hikma Pharmaceuticals USA | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Sindledecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.